Skip to main content
Clinical Trials/RBR-893zqw
RBR-893zqw
Completed
未知

Evaluation of clinical efficacy and Perceived Improvement of fatigue in the legs and feet

Medcin Instituto da Pele0 sitesMay 14, 2015

Overview

Phase
未知
Intervention
Not specified
Conditions
Chronic Venous Insufficiency
Sponsor
Medcin Instituto da Pele
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 14, 2015
End Date
TBD
Last Updated
2 years ago
Study Type
Intervention
Sex
Female

Investigators

Sponsor
Medcin Instituto da Pele

Eligibility Criteria

Inclusion Criteria

  • Volunteer female; aged 35\-65 years with a history of Chronic Venous Insufficiency; with complaints of episodes of edema, fatigue and heaviness in the legs and feet, agreement to abide by the procedures of the trial and attend the clinic in the days and schedules
  • determined for the application and readings and Signing the consent form

Exclusion Criteria

  • Pregnant; lactating or planning to become pregnant during the study period; use of the following drugs of topical or systemic use immunosuppressants, antihistamines, NSAIDs, and corticosteroids within 30 days before the selection or considering
  • immunosuppressants, the interval should be 3 months before screening; atopic or allergic to cosmetics history; pathologies and / or active skin lesions in the area of review (local and or / disseminated); skin marks in the experimental area that interfere with evaluation of possible skin reactions
  • (vascular malformations, scars, increasing hairiness, nevus aplenty, sunburn); diseases which cause immune suppression, such as diabetes, HIV;
  • endocrine disorders such as thyroid, ovarian or adrenal gland disorders; volunteers with congenital or acquired immunodeficiency known; relevant medical history or current evidence of alcohol or other drugs;
  • History known or suspected intolerance to products of the same category; intense sun exposure up to 15 days before evaluation; or dermatological aesthetic treatment in the assessment area up to 04 weeks before screening;
  • professionals directly involved in the study design; other conditions considered by the medical examiner as reasonable for disqualification from participation in the study

Outcomes

Primary Outcomes

Not specified

Similar Trials